ARTICLE | Clinical News

J&J preclinical data

August 2, 2010 7:00 AM UTC

In vitro, SQ109 in combination with TMC207 reduced the minimal inhibitory concentration of TMC207 alone for Mycobacterium tuberculosis by 4- to 8-fold, and improved the rate of killing of TB bacteria compared to the rate for each compound alone. Data were published in Antimicrobial Agents and Chemotherapy. ...